Acclaimed physician-scientist and biotechnology innovator with extensive experience in advancing molecular discovery through successful commercialization. Expertise encompasses cardiology, neurology, innate immunity, pediatrics, and neonatal intensive care, contributing to significant advancements in the prevention, diagnosis, and treatment of acute life-threatening diseases. Proven track record of directing science portfolios exceeding $700 million at NIH, NSF, and leading academic health systems, demonstrating a commitment to impactful basic and translational research. Dedicated mentor to over 50 trainees, many of whom have emerged as influential leaders in the biotech and pharmaceutical sectors.